한글목차

개요

에피네프린 자기주사기 시장은 2023-20281년에 24억 4,000만 달러, 예측 기간 중 CAGR은 10.59%로 성장할 것으로 예측됩니다.

에피네프린 자기주사기 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 알레르기의 유병률 증가, 벤더에 의한 마케팅 전략의 혁신 증가, 아나필락시스에 대한 의식의 향상, 혁신적인 에피네프린 자기주사기의 이용 가능성 증가 등이 촉진하고 있습니다.

본 조사에서는 향후 수년간 에피네프린 자기주사기 시장 성장을 촉진하는 주요 요인의 하나로 벤더에 대한 정부 압력에 의한 빈번한 제품 발매를 들고 있습니다. 또한 에피네프린 자기주사기에 관한 인지도의 향상 및 벤더나 기타 조직이 제공하는 환자 지원 프로그램의 증가는 시장의 큰 수요로 연결될 것으로 전망됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계의 에피네프린 자기주사기 시장 2018-2022
• 유형 부문 분석 2018-2022
• 최종사용자 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• 0.30그램 : 시장 규모와 예측 2023-2028
• 0.15그램 : 시장 규모와 예측 2023-2028
• 0.50그램 : 시장 규모와 예측 2023-2028
• 시장 기회 : 유형별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원과 진료소 : 시장 규모와 예측 2023-2028
• 홈케어 : 시장 규모와 예측 2023-2028
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황의 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계의 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Adamis Pharmaceuticals Corp.
• ALK Abello AS
• Amneal Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• BIOPROJET
• Crossject
• Halozyme Therapeutics Inc.
• kaleo Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

제13장 부록

영문목차

Abstract

The epinephrine autoinjector market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 10.59% during the forecast period. The report on the epinephrine autoinjector market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies, rising innovations in marketing strategies by vendors, and rise in awareness of anaphylaxis and availability of innovative epinephrine autoinjectors.

Technavio's epinephrine autoinjector market is segmented as below:

By Type

• 0.30gm
• 0.15gm
• 0.50gm

By End-user

• Hospitals
• clinics
• Homecare

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the frequent product launches due to government pressure on vendors as one of the prime reasons driving the epinephrine autoinjector market growth during the next few years. Also, growing awareness about epinephrine autoinjectors and increase in patient assistance programs offered by different vendors and other organizations will lead to sizable demand in the market.

The report on the epinephrine autoinjector market covers the following areas:

• Epinephrine autoinjector market sizing
• Epinephrine autoinjector market forecast
• Epinephrine autoinjector market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epinephrine autoinjector market vendors that include Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the epinephrine autoinjector market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global epinephrine autoinjector market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global epinephrine autoinjector market 2018 - 2022 ($ billion)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 0.30gm - Market size and forecast 2023-2028
• Exhibit 34: Chart on 0.30gm - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on 0.30gm - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on 0.30gm - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on 0.30gm - Year-over-year growth 2023-2028 (%)
• 6.4 0.15gm - Market size and forecast 2023-2028
• Exhibit 38: Chart on 0.15gm - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on 0.15gm - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on 0.15gm - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on 0.15gm - Year-over-year growth 2023-2028 (%)
• 6.5 0.50gm - Market size and forecast 2023-2028
• Exhibit 42: Chart on 0.50gm - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on 0.50gm - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on 0.50gm - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on 0.50gm - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Type
• Exhibit 46: Market opportunity by Type ($ billion)
• Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user
• 7.3 Hospitals and clinics - Market size and forecast 2023-2028
• Exhibit 52: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
• 7.4 Homecare - Market size and forecast 2023-2028
• Exhibit 56: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Homecare - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ billion)
• Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Adamis Pharmaceuticals Corp.
• Exhibit 111: Adamis Pharmaceuticals Corp. - Overview
• Exhibit 112: Adamis Pharmaceuticals Corp. - Business segments
• Exhibit 113: Adamis Pharmaceuticals Corp. - Key offerings
• Exhibit 114: Adamis Pharmaceuticals Corp. - Segment focus
• 12.4 ALK Abello AS
• Exhibit 115: ALK Abello AS - Overview
• Exhibit 116: ALK Abello AS - Product / Service
• Exhibit 117: ALK Abello AS - Key offerings
• 12.5 Amneal Pharmaceuticals Inc.
• Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
• Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
• Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
• Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
• 12.6 Bausch Health Companies Inc.
• Exhibit 123: Bausch Health Companies Inc. - Overview
• Exhibit 124: Bausch Health Companies Inc. - Business segments
• Exhibit 125: Bausch Health Companies Inc. - Key news
• Exhibit 126: Bausch Health Companies Inc. - Key offerings
• Exhibit 127: Bausch Health Companies Inc. - Segment focus
• 12.7 BIOPROJET
• Exhibit 128: BIOPROJET - Overview
• Exhibit 129: BIOPROJET - Product / Service
• Exhibit 130: BIOPROJET - Key offerings
• 12.8 Crossject
• Exhibit 131: Crossject - Overview
• Exhibit 132: Crossject - Product / Service
• Exhibit 133: Crossject - Key offerings
• 12.9 Halozyme Therapeutics Inc.
• Exhibit 134: Halozyme Therapeutics Inc. - Overview
• Exhibit 135: Halozyme Therapeutics Inc. - Product / Service
• Exhibit 136: Halozyme Therapeutics Inc. - Key offerings
• 12.10 kaleo Inc.
• Exhibit 137: kaleo Inc. - Overview
• Exhibit 138: kaleo Inc. - Product / Service
• Exhibit 139: kaleo Inc. - Key offerings
• 12.11 Pfizer Inc.
• Exhibit 140: Pfizer Inc. - Overview
• Exhibit 141: Pfizer Inc. - Product / Service
• Exhibit 142: Pfizer Inc. - Key news
• Exhibit 143: Pfizer Inc. - Key offerings
• 12.12 Teva Pharmaceutical Industries Ltd.
• Exhibit 144: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 145: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 146: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 147: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 148: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.13 Viatris Inc.
• Exhibit 149: Viatris Inc. - Overview
• Exhibit 150: Viatris Inc. - Business segments
• Exhibit 151: Viatris Inc. - Key news
• Exhibit 152: Viatris Inc. - Key offerings
• Exhibit 153: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 154: Inclusions checklist
• Exhibit 155: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 156: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 157: Research methodology
• Exhibit 158: Validation techniques employed for market sizing
• Exhibit 159: Information sources
• 13.5 List of abbreviations
• Exhibit 160: List of abbreviations